234.70
+4.15
+(1.80%)
As of 5:39:49 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
6,288,000.00
7,164,000.00
8,519,000.00
8,358,000.00
6,208,000.00
Investing Cash Flow
-7,304,000.00
-7,081,000.00
-2,234,000.00
-12,987,000.00
-21,239,000.00
Financing Cash Flow
-8,939,000.00
-273,000.00
-2,570,000.00
1,295,000.00
1,006,000.00
End Cash Position
2,322,000.00
5,864,000.00
5,995,000.00
2,586,000.00
6,035,000.00
Capital Expenditure
-1,310,000.00
-1,383,000.00
-1,118,000.00
-1,240,000.00
-791,000.00
Issuance of Capital Stock
--
68,000.00
31,000.00
86,000.00
3,550,000.00
Issuance of Debt
-2,605,000.00
--
--
984,000.00
8,670,000.00
Repayment of Debt
-1,594,000.00
-620,000.00
-965,000.00
-1,282,000.00
-5,959,000.00
Repurchase of Capital Stock
-5,170,000.00
--
--
--
--
Free Cash Flow
4,978,000.00
5,781,000.00
7,401,000.00
7,118,000.00
5,417,000.00
12/31/2020 - 3/5/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NN6.F NanoRepro AG
1.4800
+5.34%
ESF0.MU Eurofins Scientific SE
50.22
+2.03%
IDHCl.XC
TN8.F Thermo Fisher Scientific Inc.
530.90
-0.67%
MVF.AX Monash IVF Group Limited
1.2050
-2.82%
VIMIAN.ST Vimian Group AB (publ)
37.35
+0.81%
PRM.L Proteome Sciences plc
4.2500
-11.46%
GDR.L genedrive plc
2.2500
+4.65%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%
LZAGY Lonza Group AG
59.17
-2.18%